Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance.

Latest News

August 3, 2022 Veeva to Release Fiscal 2023 Second Quarter Results on August 31, 2022
  Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2022, after market close on August 31, 2022. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event:              Veeva's Fiscal 2023 Second Quarter Results Conference Call Date:                Wednesday, August 31, 2022 Time:                2:00 p.m. PT (5:00 p.m. ET) Online Registration: Webcast: About Veeva Systems Veeva is the global leader in cloud software for the life sciences...
Read More
June 1, 2022 Veeva Announces Fiscal 2023 First Quarter Results
Total Revenues of $505.1M, up 16% Year Over Year;  Subscription Services Revenues of $402.6M, up 18% Year Over Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2022. "It was a great quarter of innovation and deepening our strategic partnership with the industry," said CEO Peter Gassner. "We announced major new innovations, advanced in key areas that will have very positive impacts over the long term, and got the industry back together in person at Veeva Summit. Thanks to our customers for the energy and ideas as we challenge each other in our work to improve the lives of patients." Fiscal 2023 First Quarter Results: Revenues : Total revenues for the first quarter were $505.1 million, up from $433.6 million one year ago, an increase of 16% year over year. Subscription services revenues for the first quarter were $402.6 million, up from...
Read More